Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...

When Katherine Stueland was 11 years old, she went to a reunion for her mother's branch of the family tree and learned that ...

Significant alterations in the structure and cellular composition of the distal lung are a defining characteristic of pulmonary fibrosis (PF); however, the specific spatial contexts that play a role ...

Histoindex Pte Ltd. launched its laboratory-developed test for metabolic dysfunction-associated steatohepatitis (MASH), ...

MASH has long been a challenging and progressive liver disease, characterized by fat build-up and inflammation that, if left ...

Tribune raises EUR 37 million in seed and Series A funding to advance portfolio of therapies targeting central drivers of ...

Key findings include: AI-assisted digital pathology 49.2% (p=0.02 vs placebo) of 600 mg treated patients achieving a ≥1-stage improvement in fibrosis versus 25.7% of placebo treated patients as ...